Shubhangi Sathyakumar

Twitter: @parasitessk

Shubhangi received her Bachelor of Technology in Biotechnology in 2019 from the Vellore Institute of Technology in India. For her final year project, she worked on Parkinson’s disease studying the role of mRNA degradation in alpha-synucleinopathy at the Khurana Lab at Harvard Medical School (Brigham and Women’s Hospital) in Boston. Shubhangi is currently pursuing a research-based master’s in Biomedical Engineering at Carnegie Mellon University with her research at the Regenerative Biomaterials and Therapeutics Group focusing on vascularizing tissues using endothelial cells.